Conclusion
REMISSION
Patients who did not show an early response at Week 2 cannot be predicted with a high probability to also show poor improvement at Week 6. In fact, some patients who did not show early response at 2 weeks might have marked improvement at 6 weeks.We performed a post‐hoc analysis using data from the lurasidone trial to predict later responses from early improvements. Both sensitivity and negative predictive value values were higher for the remission outcome than for the response outcome.
In 2020, Kato et al.The detailed characteristics of patients included in the LUR trial are presented in Table We included 332 adults with BDep (male = 47.3%, mean age = 42.1 years, Table Correlations between and predictive value of early improvement at week 2 and response and remission at week 6Abbreviations: 95% CI, 95% confidence interval; LUR, lurasidone.A value of 